CYTK vs VRTX
Cytokinetics Inc · Vertex Pharmaceuticals Inc
Relative return (rebased to 100)
Key stats
| Metric | CYTK | VRTX |
|---|---|---|
| Price | $74.13 | $505.75 |
| Market Cap | $9.22B | $128.36B |
| P/E | — | 32.47 |
| P/B | — | 6.63 |
| P/S | 104.77 | 10.70 |
| ROE | — | 20.4% |
| Net Margin | -891.6% | 32.9% |
| Gross Margin | — | — |
| Revenue Growth | 376.6% | 8.9% |
| Dividend Yield | — | — |
| EPS | -$6.31 | $15.58 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.